A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
de Bruyn G, Vargas-Cortez M, Warren T, Tyring SK, Fife KH, Lalezari J, Brady RC, Shahmanesh M, Kinghorn G, Beutner KR, Patel R, Drehobl MA, Horner P, Kurtz TO, McDermott S, Wald A, Corey L.
de Bruyn G, et al. Among authors: kurtz to.
Vaccine. 2006 Feb 13;24(7):914-20. doi: 10.1016/j.vaccine.2005.08.088. Epub 2005 Sep 21.
Vaccine. 2006.
PMID: 16213066
Clinical Trial.